X2UR0P9Supplement Left Upper Extremity Vein with Synthetic Substitute, Extraluminal Support Device, Open Approach, New Technology Group 9
- Billable / Specific Code
X2UR0P9 is a billable ICD-10-PCS procedure code for Supplement Left Upper Extremity Vein with Synthetic Substitute, Extraluminal Support Device, Open Approach, New Technology Group 9. It is valid on HIPAA claims for fiscal year 2026 (October 1, 2025 through September 30, 2026) and groups to 6 MS-DRGs. The root operation Supplement involves putting in or on biological or synthetic material that physically reinforces and/or augments the function of a portion of a body part.
Code Identity
PCS Table Breakdown
Each ICD-10-PCS code is built from seven characters, each an axis of the procedure. Hover or tap the icons for the official CMS definitions.
| Position | Designation | Value | Meaning |
|---|---|---|---|
| 1 | Section | X | New Technology |
| 2 | Body System | 2 | Cardiovascular System |
| 3 | Operation | U | Supplement |
| 4 | BodyPart | R | Upper Extremity Vein, Left |
| 5 | Approach | 0 | Open |
| 6 | Device/Substance/Technology | P | Synthetic Substitute, Extraluminal Support Device |
| 7 | Qualifier | 9 | New Technology Group 9 |
Code History
- 05UY0JZ — Supplement Upper Vein with Synth Sub, Open Approach
Similar Procedure Codes
Questions About X2UR0P9
Is X2UR0P9 a billable code?
Yes. X2UR0P9 is a complete seven-character ICD-10-PCS code, specific enough to report Supplement Left Upper Extremity Vein with Synthetic Substitute, Extraluminal Support Device, Open Approach, New Technology Group 9 on inpatient claims from October 1, 2025 through September 30, 2026.
What do the characters in X2UR0P9 mean?
X2UR0P9 breaks down character by character: the 1st character X is the Section (New Technology); the 2nd character 2 is the Body System (Cardiovascular System); the 3rd character U is the Operation (Supplement); the 4th character R is the BodyPart (Upper Extremity Vein, Left); the 5th character 0 is the Approach (Open); the 6th character P is the Device/Substance/Technology (Synthetic Substitute, Extraluminal Support Device); the 7th character 9 is the Qualifier (New Technology Group 9).
What MS-DRG does X2UR0P9 group to?
On an inpatient stay, Supplement Left Upper Extremity Vein with Synthetic Substitute, Extraluminal Support Device, Open Approach, New Technology Group 9 maps to MS-DRGs 252, 253, 254, 907, 908, 909, with relative weights from 1.3127 to 3.8393. The MS-DRG sets the fixed Medicare payment for the stay.
